Related resources and publications
Humanized VISTA mouse & Pharmacokinetics
Humanized ICP mouse and cell lines
Humanized PD-1/PD-L1 mouse and cell line
Front Immunol
J Allergy Clin Immunol
J Immunother Cancer
Nat Cancer
The hPD-1/hVISTA mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint PD-1 and/or VISTA in fully immunocompetent mice.
The double-humanized PD-1 and VISTA mouse model (hPD-1/hVISTA) was generated by intercrossing hPD-1 and hVISTA mice.
hPD-1 has been developed by inserting, within the mouse PD-1 locus, a chimeric PD-1 with a human extracellular domain, a murine transmembrane domain and a murine intracellular domain. hVISTA has been developed by inserting, within the mouse VISTA locus, a chimeric VISTA with a human extracellular, human transmembrane and murine intracellular domain.
Both hPD-1 and hVISTA expressions are regulated by endogenous mouse promoters.
hPD-1 and mPD-1 expression on αCD3/αCD28-activated splenocytes on Tregs (A) and conventional CD4+ (B) at day 2 of culture, and on CD8+ T cells (C) at the indicated time points.
hVISTA and mVISTA expression on freshly isolated splenocytes on Tregs, conventional CD4+, and CD8+ T cells.
Humanized VISTA mouse & Pharmacokinetics
Humanized ICP mouse and cell lines
Humanized PD-1/PD-L1 mouse and cell line
Front Immunol
J Allergy Clin Immunol
J Immunother Cancer
Nat Cancer
The hGITR/Foxp3 mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint GITR. The red fluorescent protein regulated under the Foxp3 promoter allows you to efficiently monitor and sort Foxp3-expressing cells from different lymphocyte lineages and lymphoid organs.
Let us know how we can help